SG Americas Securities, LLC
Broker-DealerPosition in CYTK — Cytokinetics Inc
CIK 1313360
NEW YORK, NY
Position in CYTK
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,949,618
+$1,332,121 QoQ
Shares Held
34,624
+41.1% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#191
of 477 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SG Americas Securities, LLC holds $1,085,838,933 across 181 Biotechnology names. CYTK ranks #27 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
427,703 | $266,689,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
523,720 | $260,147,435 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
2,052,906 | $75,546,940 | |
| 4 | CGON |
CG Oncology, Inc.
|
867,465 | $61,633,388 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
605,581 | $49,397,242 | |
| 6 | ASND |
Ascendis Pharma A/S
|
161,026 | $42,948,854 | |
| 7 | RPRX |
Royalty Pharma plc
|
688,590 | $38,609,241 | |
| 8 | BNTX |
BioNTech SE
|
347,131 | $32,300,539 |
All Filings in CYTK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,949,618 | 34,624 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,617,497 | 24,541 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $2,045,733 | 32,196 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $2,824,779 | 51,397 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $265,905 | 8,048 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $270,518 | 6,731 | Shares | Sole | 2025-04-15 | |
| 2024-09-30 | $1,172,318 | 22,203 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $7,484,533 | 138,142 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $636,949 | 9,085 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $1,933,461 | 23,158 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $718,205 | 24,379 | Shares | Sole | 2023-10-13 | |
| 2023-03-31 | $1,641,754 | 46,654 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $160,278 | 3,498 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $270,883 | 5,591 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $362,332 | 9,222 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,827,395 | 49,644 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $2,908,049 | 63,801 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $2,392,042 | 66,929 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $332,016 | 16,777 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $473,364 | 20,351 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $645,364 | 31,057 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $716,961 | 33,116 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $380,113 | 16,127 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $563,137 | 47,764 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||